Booker Says Marijuana Reform Can Pass ‘Now’ During Lame Duck Or ‘Many Years From Now’ After GOP Takes House Control
FeaturedMarijuana IndustryMarijuana Industry News November 14, 2022 0
With Republicans projected to win a majority of the House of Representatives after last week’s midterm elections, Sen. Cory Booker (D-NJ) says Democrats who want to enact marijuana reform must either do it “now” during the lame duck session or wait until “many years from now” when his party... Read more
House Democrats And Republicans Publish ‘Joint Memo’ On Marijuana Ahead Of Congressional Legalization Hearing
FeaturedMarijuana IndustryMarijuana Industry News November 14, 2022 0
House Democrats and Republicans have co-published a joint memo ahead of a congressional subcommittee meeting on marijuana on Tuesday, laying out key background details on the issue that will likely inform the conversation at the meeting. The House Oversight Subcommittee on Civil Rights and Civil Liberties announced the meeting—titled... Read more
Colorado Governor ‘Excited’ About Psychedelics Legalization Vote, Touting ‘Promising’ Medical Benefits Despite Not Endorsing Before Election
FeaturedMarijuana IndustryMarijuana Industry News November 14, 2022 0
The governor of Colorado says he’s “excited” about the state’s historic vote last week to legalize psychedelics and create psilocybin healing centers, calling it a “promising” treatment option for certain mental health conditions. During an appearance on HBO’s “Real Time with Bill Maher” on Friday, Gov. Jared Polis (D)... Read more
Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights
November 14, 2022
Ryan Allway November 14th, 2022 News, Top News Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with Fragile X syndrome (FXS); topline results expected second-half 2023 $55.9 million in cash and cash equivalents at September 30, 2022; Cash runway into first quarter 2024... Read more
